Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted a quarterly certificate to the stock exchanges under SEBI Regulation 74(5) for the quarter ended 31st December 2025. The certificate was issued by their Registrar and Share Transfer Agent, MUFG Intime India Private Limited. It confirms that physical share certificates received from depository participants for dematerialisation during the quarter were duly verified, processed, and either accepted or rejected. Cancelled physical certificates were mutilated, and the depositories' names have been substituted in the register of members within the required timelines.
This is a routine regulatory compliance filing with no impact on company financials, operations, or shareholder value. It simply confirms orderly processing of share dematerialisation requests for the October–December 2025 quarter.